Previous drugs to treat the disease have failed and were never approved: An effort from Centocor went down in 1992, and drugs from Chiron (nasdaq: CHIR - news - people ) and Synergen failed in 1994.

FORBES: FDA Gives Conditional Approval To Lilly's Xigris